Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related THOR
Thoratec Receives Approval From FDA For Full Expansion Of HeartMate III™ U.S. IDE Clinical Trial
Credit Suisse Reiterates Outperform, Raises Price Target On Thoratec On Updated LVAD Estimates
Related AMD
Semiconductor Shipments Are Weak (Because Of PCs)
Stock Market On Edge As Tech Lights Up Earnings Marquee
AMD: Still A Good Short To $2 Per Share In 2015 (Seeking Alpha)

Analysts at Goldman Sachs upgraded Thoratec (NASDAQ: THOR) from “neutral” to “buy.” The target price for Thoratec is set to $46. Thoratec's shares closed at $38.31 on Friday.

Wedbush upgraded Advanced Micro Devices (NYSE: AMD) from “neutral” to “outperform.” The target price for Advanced Micro Devices has been raised from $4.50 to $5. AMD's shares closed at $3.83 on Friday.

Analysts at Cowen & Company upgraded St. Jude Medical (NYSE: STJ) from “underperform” to “market perform.” The target price for St. Jude Medical has been raised from $38 to $53. St. Jude Medical's shares closed at $55.16 on Friday.

Analysts at Miller Tabak upgraded Dunkin' Brands Group (NASDAQ: DNKN) from “hold” to “buy.” The target price for Dunkin' Brands Group has been raised from $46 to $53. Dunkin' Brands Group's shares closed at $45.68 on Friday.

Latest Ratings for THOR

DateFirmActionFromTo
Apr 2015OppenheimerMaintainsOutperform
Apr 2015Wunderlich
Feb 2015Canaccord GenuityMaintainsBuy

View More Analyst Ratings for THOR
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (AMD + DNKN)

Around the Web, We're Loving...

Get Benzinga's Newsletters